tirzepatide obesity nejm vs Semaglutide for – NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine • Tirzepatide: −20.2% weight loss at 72 wks • Semaglutide: −13.7% • Greater waist reduction Head-to-Head: Tirzepatide Outperforms Semaglutide |

Other Conditions Other conditions besides cancer can cause night sweats, including: Autoimmune disorders Bacterial infections Overactive thyroid or thyroid disease Sleep apnea Stroke Anxiety Holistic Care for Cancer-Related Night Sweats Complementary therapies can be used to help reduce hot flashes and night sweats

Platforms like MeAgain empathize with that reality, reveal the hidden costs of fragmentation by showing how missed context delays clinician decisions, and bridge the gap by centralizing injection schedules, hydration, protein targets, side-effect timelines, and trend visuals, so clinicians see signal rather than noise

@AmDiabetesAssn @ADA_DiabetesPro And the summary of the P2 trial for retatrutide in PPL with #obesity #ADA2023 @AmDiabetesAssn @ADA_Pubs #weightloss

Wasabi and Ginger For some, spicy condiments like wasabi can trigger heartburn

The 7.2 mg dose could provide additional benefits for patients who require a higher magnitude of body weight loss, and stratification of patients who could benefit from the higher dose will play a large role in the management of obesity, Wharton and colleagues wrote